A thesis of inclusive flourishing
Health & Wellbeing Technologies
Tools to transform physical and mental health including medtech, biotech, deep digital healthtech, including through prevention and early-intervention.
The First 1000
Days of Life
Interventions in paediatrics, prenatal diagnostics, neonatal care, early nutrition and early childhood education, development and parental engagement.
Technologies and service design to support inclusive, sustainable social support, mutual care, and preventive and restorative activities.
Tools to transform human capabilities and allow greater freedom, choice and self-management (education, participation, inclusion).
Climate Change Adaptation
Technologies that meet health system outcomes or operational needs related to climate and zero-carbon adaptation.
Through an exclusive partnership with the MedTech Actuator, Synthesis Capital has a direct line to a diverse pool of investment-ready startups primed for high growth, and access to an entire ecosystem of venture development expertise.
Born as Australia's national medtech venture catalyst, the MedTech Actuator is now one of the Asia-Pacific's leading healthtech commercialisation initiatives, with an outstanding history of success and impact.
By deftly blending finance with active risk management and milestone-based scaling, Synthesis Capital has a distinctive and unprecedented competitive advantage. We're not just investing; we're fostering a new generation of world-leading health enterprises.
Supercharge your commercialisation journey
Are you developing a transformative technology or insight with the potential and aspiration for large-scale health impact?
Is your proposition grounded in deep technology, demanding the right approach to IP and regulation?
Is your team driven by passion and purpose, and would you benefit from access to the Asia-Pacific's leading healthtech commercialisation ecosystem?
If yes, then we would love to hear from you!
Synthesis Capital is the catalyst your innovation needs. We are more than an investor; we are your strategic partner, bringing a powerful ecosystem and venture development process dedicated to nurturing your startup's potential, smoothing your journey, and supercharging your route to market.
Let's charge into the future of health - together.
Investing in tomorrow's health innovations, today
Synthesis Capital is inviting investors to become a part of our mission to revolutionise health and wellbeing enhancement.
Based in Melbourne, Australia, we harness the potential of an Asia-Pacific wide ecosystem.
Our exclusive partnership with the MedTech Actuator enriches our venture pipeline, offering direct access to companies that have undergone rigorous assessment and commercialisation development.
We target returns of over 25% net of fees, carry and expenses.
Our investors enjoy optimised tax benefits including a 10% tax offset and tax-free returns, facilitated by our conditional ESCLP registration, with investment flexibility provided through a stapled managed investment trust.
At Synthesis Capital, your investment doesn't just yield financial returns - it contributes to health impact and systemic transformation in the healthcare sector.